Nrx pharmaceuticals, inc. announces proposed underwritten public offering of common stock

Radnor, pa. , april 17, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp)("nrx pharmaceuticals" or the "company"), a clinical-stage biopharmaceutical company, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering.

NRXP Ratings Summary

NRXP Quant Ranking